Alsup Mulls $113M Atty Fees In $454M Glumetza Antitrust Deal

By Hannah Albarazi · January 20, 2022, 5:57 PM EST

U.S. District Judge William H. Alsup said on Thursday he will grant final approval to $454 million in settlements resolving direct Glumetza buyers' class claims that drugmakers plotted to delay the...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

In Re Glumetza Antitrust Litigation

Case Number

3:19-cv-05822

Court

California Northern

Nature of Suit

Anti-Trust

Date Filed

September 18, 2019